CSIDB logo
Incident

Uppsala Monitoring Centre

Incident posture

Attack window
Jan 2024
Location
Sweden
Status
Historical
CIA posture
Available to members
Updated
2026-01-04 18:20

Linked entities

Victim
Uppsala Monitoring Centre
Threat actors
0 actors
Sources
1 source

Timeline

Occurred
Jan 2024
Discovered
Pending
Disclosed
Pending
Resolved
Pending

Summary

A cyber attack targeting the IT provider Tietoevry disrupted Uppsala Monitoring Centre's critical pharmaceutical applications, causing widespread service outages across WHODrug and Vigi platforms. The provider isolated affected systems following the attack on their Swedish data center, impacting numerous organizations including UMC's drug monitoring and safety tools. Most services—including VigiFlow, VigiLyze, WHODrug Insight, and user access portals—remained non-operational, while Vaccine eReporting and primary eReporting functions were restored. The organization activated a crisis team to coordinate recovery efforts and communicate updates, though restoration timelines remain uncertain. No evidence of data compromise was identified during the incident.

Motives

Detailed motive labels are available to members.

1 motive

TTPs

Detailed technique labels are available to members.

1 technique

Description

On the night of January 19-20, 2024, IT services provider Tietoevry detected a cyber attack targeting one of its data centers in Sweden, which hosted critical infrastructure for Uppsala Monitoring Centre (UMC). Tietoevry responded by isolating affected systems to contain the incident, but this action caused widespread service disruptions across UMC’s WHODrug and Vigi application portfolios. The attack’s impact became apparent on January 20 when UMC announced service unavailability across multiple platforms, affecting pharmaceutical safety monitoring systems used by the Programme for International Drug Monitoring members and other stakeholders. By January 23, 2024, operational status updates showed significant ongoing outages: VigiBase API, VigiFlow, VigiLyze, and seven WHODrug services remained completely non-operational, while WHODrug Download API was partially functional. Vaccine eReporting, VigiAccess, VigiMobile, and Primary eReporting were among the few services restored to normal operation during this period.

UMC activated a crisis management team to coordinate incident response, maintain communication with Tietoevry, and prepare for service restoration once infrastructure repairs concluded. Director Dr. Peter Hjelmström publicly acknowledged the severity of the disruption, apologizing to stakeholders while clarifying that recovery timelines remained uncertain as Tietoevry continued remediation work. UMC confirmed no evidence of data compromise but maintained continuous monitoring of its systems throughout the outage. The organization provided daily status updates via its website and email subscriptions, detailing affected services and advising users to contact support for unresolved technical issues. Service interruptions persisted beyond January 23, with critical drug safety tools like WHODrug Insight, WHODrug Koda, and VigiBase Custom Searches remaining offline due to dependencies on Tietoevry’s compromised infrastructure.

Sources

Sources available to members: 1 source.

CSIDB